CV Ventures

CV Ventures is the venture capital and innovation arm of the Cardiovascular Institute of the South (CIS), one of the largest cardiovascular practices in the United States. The firm focuses on identifying, investing in, and developing early-stage cardiovascular technologies, including medical devices, diagnostics, and digital health solutions. By leveraging the clinical expertise and patient volume of CIS, CV Ventures provides a unique platform for the validation and commercialization of innovative heart and vascular treatments. The firm's portfolio includes several high-profile cardiovascular startups that have achieved significant clinical and regulatory milestones, including successful acquisitions by major medical device companies. CV Ventures operates as a venture studio, providing both capital and clinical guidance to accelerate the development of life-saving cardiovascular interventions.